Chordoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Conditions:   Chordoma;   Locally Advanced Chordoma;   Metastatic Chordoma;   Unresectable Chordoma Interventions:   Biological: Nivolumab;   Biological: Relatlimab Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2018 Category: Research Source Type: clinical trials

Phase 2 Brachyury Chordoma
Condition:   Chordoma Intervention:   Biological: BN-Brachyury plus radiation Sponsor:   Bavarian Nordic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2018 Category: Research Source Type: clinical trials